Medical Oncologist
On Olaparib (Lynparza)
Tests and Monitoring — While You Are on Olaparib
Olaparib changes how often you need blood tests. Monthly checks are standard from the start, because this drug can lower your blood counts in ways that are manageable — but only if they are caught early.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Monthly blood tests — A full blood count is the key check — it looks at red cells, white cells and platelets all at once.
- Three cell types watched — Each tells a different story: red cells affect energy, white cells affect infection risk, platelets affect clotting.
- Results guide dosing — A low count often means a brief pause or dose adjustment, not a permanent stop.
- Kidney and liver checked too — Less often than blood counts, but both are tested at the start and periodically throughout treatment.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
On olaparib, blood tests — particularly your full blood count — are checked monthly. They look for changes in your red cells, white cells and platelets that are common with this drug. Your team uses these results to decide whether to continue at the same dose, reduce it, or pause briefly.
Which tests are done, and what does each result mean?
| Test | What it checks | When it runs | What a concerning result means for you |
|---|---|---|---|
| Full blood count (FBC) | All three blood cell types at once — red cells, white cells and platelets | Before you start, then monthly for at least the first year | One or more counts outside the normal range may lead to a dose pause or reduction until they recover |
| Haemoglobin (part of FBC) | The oxygen-carrying protein in red cells — this is what falls when you feel unusually tired or breathless | Monthly | A significant fall may lead to a dose reduction, a pause, or in some cases a transfusion — decided by your symptoms as well as the number |
| Neutrophils (part of FBC) | Your main infection-fighting white cells | Monthly | A low count raises your infection risk. Fever or chills with a low neutrophil count is a same-day call to your team |
| Platelets (part of FBC) | The cell fragments that help blood clot | Monthly | Low platelets increase your risk of bruising and bleeding that is hard to stop. Unusual bleeding between tests is worth reporting even before your next appointment |
| Kidney function (creatinine / eGFR) | How well your kidneys are clearing olaparib | At baseline and periodically — more often if you have pre-existing kidney disease | Reduced kidney function can affect how the drug accumulates in your body, and your dose may need adjusting |
| Liver function tests (LFTs) | Whether the liver is processing normally | At baseline and periodically | Raised enzyme levels are investigated; significant liver changes are less common than blood count changes on olaparib |
What happens if a result comes back abnormal?
Your team has a planned response for every abnormal result — you will not be left guessing what to do.
The most common action is a temporary dose reduction or a short pause, followed by restarting once your counts have recovered. Most people are able to continue on olaparib after an adjustment.
If blood counts stay persistently low and do not recover as expected despite dose changes, NCCN guidance recommends a bone marrow assessment. This is to rule out a rare condition called myelodysplastic syndrome (MDS), which has been reported in a small proportion of patients on PARP inhibitors. Catching it early is what makes it treatable.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What happens at each monitoring appointment?
Blood draw
A blood sample is taken — usually before you see the doctor, so the results are ready during your consultation.
Results reviewed
Your oncologist compares each count with your previous results. A single low reading is looked at differently from a falling trend across several months.
Symptoms discussed
You will be asked about tiredness, breathlessness, bruising, bleeding, or any sign of infection since your last visit. These matter as much as the numbers.
Dose decision made
Based on results and symptoms together, your team decides whether to continue at the same dose, adjust, or pause. You should leave knowing which one.
Next appointment confirmed
If a result needs watching more closely, your team may schedule appointments more frequently than monthly until it stabilises.
Did you know?
Anaemia — a fall in haemoglobin — is the most commonly reported blood count change in patients on olaparib and one of the leading reasons a dose adjustment is made.
It is almost always manageable with dose modification and does not usually mean olaparib has to stop permanently.
Source: NCCN Clinical Practice Guidelines in Oncology
Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics
Drug Deep Dive: Olaparib (Lynparza)
- Adjuvant Olaparib After Early Breast Cancer Surgery
- Anaemia and Extreme Fatigue on Olaparib
- Blood Cancer Risk After Long-Term Olaparib: How Real Is It?
- Diet and Nutrition While on Olaparib
- Drug, Food and Supplement Interactions With Olaparib
- Fertility, Pregnancy and Contraception on Olaparib
- How Does Olaparib Work? The PARP Inhibitor Explained
- How Long Does Olaparib Take to Work?
- How Long Will You Stay on Olaparib?
- Maintenance Olaparib: Taking a Drug When There Is No Visible Cancer
- Nausea on Olaparib: Managing the Most Common Side Effect
- Olaparib (Lynparza, Olanib): The Complete Patient Guide
- Olaparib Myths: 'Only for BRCA', 'It's Chemo', 'It Causes Cancer'
- Olaparib Price in India: Brand, Generic and Monthly Cost
- Olaparib Side Effects: The Complete List and Timeline
- Olaparib Success Rate and Survival: An Honest Look at the Numbers
- Olaparib With Bevacizumab or Hormone Therapy: Combination Regimens
- Olaparib in Elderly Patients and Those With Other Illnesses
- Olaparib vs Niraparib vs Talazoparib: Comparing PARP Inhibitors
- Taking Olaparib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Olaparib
- When Olaparib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Olaparib? BRCA-Mutated Ovarian, Breast, Prostate and Pancreatic Cancer
- Will Insurance or a Government Scheme Pay for Olaparib?
- Work, Travel and Daily Life on Olaparib
Drug Deep Dive: Pazopanib (Votrient)
- Diarrhoea and Blood Pressure Rise on Pazopanib
- Diet and Nutrition While on Pazopanib
- Drug, Food and Supplement Interactions With Pazopanib
- Fertility, Pregnancy and Contraception on Pazopanib
- Hair Turning White and Skin Lightening on Pazopanib
- How Does Pazopanib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Pazopanib Take to Work?
- How Long Will You Stay on Pazopanib?
- Liver Toxicity on Pazopanib: Why LFTs Are Checked Every Two Weeks
- Pazopanib (Votrient, Pazonib): The Complete Patient Guide
- Pazopanib Combinations: Why It Is Usually Given Alone
- Pazopanib Myths: Hair Colour, Liver Damage and Stopping Early
- Pazopanib Price in India: Brand, Generic and Monthly Cost
- Pazopanib Side Effects: The Complete List and Timeline
- Pazopanib Success Rate and Survival: An Honest Look at the Numbers
- Pazopanib for Soft Tissue Sarcoma: What It Can and Cannot Do
- Pazopanib in Elderly Patients and Those With Other Illnesses
- Pazopanib in Kidney Cancer vs Sarcoma: Two Different Treatment Goals
- Pazopanib vs Sunitinib: Comparing Toxicity and Quality of Life
- Taking Pazopanib on an Empty Stomach: Why the Timing Rule Exists
- Tests and Monitoring While You Are on Pazopanib
- When Pazopanib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Pazopanib? Kidney Cancer and Soft Tissue Sarcoma
- Will Insurance or a Government Scheme Pay for Pazopanib?
- Work, Travel and Daily Life on Pazopanib
Drug Deep Dive: Sunitinib (Sutent)
- Diet and Nutrition While on Sunitinib
- Drug, Food and Supplement Interactions With Sunitinib
- Fertility, Pregnancy and Contraception on Sunitinib
- Hand-Foot Skin Reaction on Sunitinib: Prevention From Day One
- How Does Sunitinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sunitinib Take to Work?
- How Long Will You Stay on Sunitinib?
- Mouth Sores, Taste Loss and Yellow Skin Discolouration on Sunitinib
- Sunitinib (Sutent, Sunitix): The Complete Patient Guide
- Sunitinib After Kidney Surgery and for GIST: Two Different Settings
- Sunitinib Myths: Hair Colour Change, Dose Cuts and 'Weaker Treatment'
- Sunitinib Price in India: Brand, Generic and Monthly Cost
- Sunitinib Side Effects: The Complete List and Timeline
- Sunitinib Success Rate and Survival: An Honest Look at the Numbers
- Sunitinib and Immunotherapy: Where Combinations Fit in Kidney Cancer
- Sunitinib in Elderly Patients and Those With Other Illnesses
- Sunitinib vs Pazopanib vs Cabozantinib for Kidney Cancer
- Taking Sunitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sunitinib
- The 4-Weeks-On, 2-Weeks-Off Sunitinib Schedule and the 2/1 Alternative
- Thyroid Failure and Fatigue on Sunitinib: The Test to Repeat Every Cycle
- When Sunitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sunitinib? Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumours
- Will Insurance or a Government Scheme Pay for Sunitinib?
- Work, Travel and Daily Life on Sunitinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
How long do I need to keep getting monthly blood tests?
Monthly monitoring is standard for at least the first year on olaparib, because blood count changes are most likely to emerge in this period. After the first year, if your counts have remained stable, your oncologist may space out the tests — but how often depends on your individual results and overall health. Do not assume you can skip a test without asking your team first, even if you are feeling well.
What symptoms should I report between blood tests?
Call your team the same day if you develop a fever, feel unusually cold and shivery, notice bleeding that is hard to stop, or see unusual bruising. These can be signs that your blood counts have fallen significantly between scheduled tests. Extreme tiredness or breathlessness on minimal activity is also worth a same-day call rather than waiting for your next appointment. You do not need the blood test result before calling — report the symptom first.
Will low blood counts mean I have to stop olaparib permanently?
Not usually. A dose reduction or temporary pause is the standard first step when counts fall, and most people are able to restart after a short break and continue treatment. Permanent discontinuation is considered only when counts do not recover despite dose adjustment, or when a more serious complication has developed alongside them. Ask your oncologist what the plan would be if your counts were to fall, so you understand the process before it happens.
What is MDS and should I be worried about it?
Myelodysplastic syndrome (MDS) is a rare blood condition that affects how the bone marrow makes blood cells. It has been reported in a small proportion of patients on PARP inhibitors including olaparib. NCCN recommends testing for it if your blood counts stay low and do not recover normally — which is exactly why ongoing monitoring matters. Worrying about it in advance is less useful than attending every scheduled test, which is the thing that catches it early when it is still treatable.
Do I need to fast before my blood test?
No fasting is required for the routine blood tests done on olaparib — full blood count, kidney function and liver function are all done without fasting. You can eat and drink normally beforehand. If your team ever requests an additional test that does require fasting, they will tell you in advance. When in doubt, call the clinic the evening before your appointment and ask.